PRYTEK
23.7.2021 03:02:11 CEST | Business Wire | Press release
Aligned with Prytek’s strategy on building technologies and delivering managed services, it is building a new software testing arm by merging its own Technological company prooV™ with QAssure, a leading Asia based software testing company. After the merger Prytek will be the major shareholder providing software testing and prooV™ of Concept as a Service to the global market. Prytek is leading with the concept of BOPaaS (Business Operating Platform as Service) where it is lifting out entire operations from corporates providing them an entire operational solution based on Prytek technologies. The group operated in several sectors such as Financial Services, Cyber & Tech Education and HR sectors. This concept helps CEOs focus on their core business and outsource all banking regulations, software, and education requirements to Prytek.
QAssure and prooV™ announced their agreement to merge under the name of QAssure with Durairaj Dhanasekaran as its CEO. QAssure market-leading testing company head quartered in Singapore with a continuous testing technology platform and managed service capability. prooV™ owned by Prytek, is the first and only end-to-end proof-of-concept platform for third-party software, enabling global enterprises to evaluate and adopt the right new technologies safely, at a fraction of the time and cost. The combined services represent the most modern platform for accelerating open innovation and transforming software testing to keep pace with digital transformation. The combined entity will have a global presence with offices in Asia, the US, and EMEA. This integration will reflect the commitment to innovation and customer success that both companies share.
Andrey Yashunsky CEO of Prytek says “With this merger, we are creating deep tech proof of concept and digital assurance platform company that help accelerate and fast-track open innovation. With a strong implementation support centre based in Singapore, an R&D team based out of Israel and an offshore development team based out of India, we will be able to bring the best minds to build and deliver great technology and services addressing the global customer needs.”
Toby Olshanetsky, CEO and co-founder of prooV™ adds "We are very excited with this merger, in prooV™ we created the first PoC as a Service platform and now we create the first full end to end solution for technology & innovation adoption, using prooV™ and QAssure we provide a 360 offering: before, during and after the POC, enterprises can assess and test multiple technologies simultaneously to identify feature sets, scaling challenges, performance bottlenecks, and security risks before releasing an application to production".
According to Technavio, the global software testing services market has the potential to grow by USD 34.49 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 12.39%. Enterprises have started focusing more on Quality Assurance, which can be gained by the implementation of agile solutions, leading to significant investments for the advancement of the latest quality assurance & software testing services.
About QAssure:
QAssure Technologies is an Independent Software Testing Company founded in 2005. Headquartered in Singapore with an expanding presence in India, Malaysia, Indonesia and the USA, QAssure Technologies focuses on specialized QA Engineering and Testing services with continuous autonomous validation and verification platform. QAssure Technologies brings together the essential combinations of value-driven robust domain knowledge, platforms and exceptional technical capabilities and burgeoning strategic alliances for leading IT solutions. Our expanding global footprint makes it possible for us to meet the software testing demands with versatile delivery models and specialized resources.
About Proov:
prooV™ is the first and only end-to-end proof-of-concept platform for third-party software, enabling global enterprises to evaluate and adopt the right new technologies safely, at a fraction of the time and cost. prooV consolidates the PoC process into one end-to-end ecosystem. With its simplified configuration and single point of integration, prooV enables companies to complete PoCs within days, not months, to run multiple PoCs simultaneously and to quickly evaluate different technology solutions from pre-screened vendors. prooV is the must-have solution for any organization looking to fast-track innovation.
About Prytek:
Prytek is a multinational technology group that builds deep technology and SaaS solutions through a BOPaaS (Business Operating Platform-as-a-Service) which is a combination of Deep Tech Solutions with Managed Services and Capital, providing the capability to lift out entire operations to create more efficient businesses of the future. Headed by industry experts, Prytek builds businesses and ecosystems in the Financial Services, Cyber & Tech Education and HR sectors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005855/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom